Cervical Cancer, Uterine Cervical Cancer, Uterine Cervical Neoplasm
Conditions
Brief summary
Most uterine cervical high-risk human papillomavirus (HPV) infections are transient, with only a small fraction developing into cervical cancer. Family aggregation studies and heritability estimates suggest a significant inherited genetic component. Candidate gene studies and previous genome-wide association studies (GWASs) report associations between the HLA region and cervical cancer. Adopting a genome-wide approach, we aimed to establish an early warning model for a high-risk population of cervical cancer.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* (1) Case group a) Aged 25-75 years. b) Han nationality. c) Patients with cervical cancer or cervical precancerous lesions above CIN2 diagnosed by biopsy or postoperative pathological diagnosis. * (2) Control group: a) Aged 25-75 years. b) Han nationality. c) No family history of cervical cancer or precancerous lesions. d) The results of TCT examination showed no abnormality.
Exclusion criteria
* (1) suffering from other neoplastic diseases. * (2) pregnant women. * (3) those with a history of bone marrow transplantation.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Significant loci of genetic variation | 2 | The impact of genetic variance on predisposition to cervical cancer |
Countries
China